TriSalus Life Sciences, Inc.

Healthcare · Medical Devices · United States

Last price 3.7 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 227.83M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device...